Biotech Acquisition Co (Biotech Acquisition Co) EV-to-EBIT : -78.12 (As of May. 23, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Biotech Acquisition Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Biotech Acquisition Co's Enterprise Value is $292.10 Mil. Biotech Acquisition Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 was $-3.74 Mil. Therefore, Biotech Acquisition Co's EV-to-EBIT for today is -78.12.

The historical rank and industry rank for Biotech Acquisition Co's EV-to-EBIT or its related term are showing as below:

BIOT's EV-to-EBIT is not ranked ^*
in the Diversified Financial Services industry.
Industry Median: 8.38
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Biotech Acquisition Co's Enterprise Value for the quarter that ended in Sep. 2022 was $285.49 Mil. Biotech Acquisition Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 was $-3.74 Mil. Biotech Acquisition Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was -1.31%.

Biotech Acquisition Co EV-to-EBIT Historical Data

The historical data trend for Biotech Acquisition Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Acquisition Co EV-to-EBIT Chart

Biotech Acquisition Co Annual Data

Trend

Dec20

Dec21

EV-to-EBIT

-180.13

Biotech Acquisition Co Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EV-to-EBIT	Get a 7-Day Free Trial				-225.50	-180.13	-85.39	-69.09	-76.36

Competitive Comparison of Biotech Acquisition Co's EV-to-EBIT

For the Shell Companies subindustry, Biotech Acquisition Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotech Acquisition Co's EV-to-EBIT Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Biotech Acquisition Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Biotech Acquisition Co's EV-to-EBIT falls into.

Biotech Acquisition Co EV-to-EBIT Calculation

Biotech Acquisition Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	292.104	/	-3.739
	=	-78.12

Biotech Acquisition Co's current Enterprise Value is $292.10 Mil.
Biotech Acquisition Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.74 Mil.

Biotech Acquisition Co (NAS:BIOT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Biotech Acquisition Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2022 )	=	EBIT	/	Enterprise Value (Q: Sep. 2022 )
	=	-3.739	/	285.492
	=	-1.31 %

Biotech Acquisition Co's Enterprise Value for the quarter that ended in Sep. 2022 was $285.49 Mil.
Biotech Acquisition Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.74 Mil.

Biotech Acquisition Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Biotech Acquisition Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotech Acquisition Co (Biotech Acquisition Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Biotech Acquisition Co (NAS:BIOT) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

545 West 25th Street, 20th Floor, New York, NY, USA, 10001

Website

Biotech Acquisition Co is a blank check company.

Executives

Albert F Hummel	director, officer: Chief Investment Officer	PO BOX 3407, RANCHO SANTA FE CA 92067
Biotech Sponsor Llc	10 percent owner	545 W. 25TH ST., 20TH FLOOR, NEW YORK NY 10001
Bruno Montanari	director	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Ivan Jarry	officer: Chief Operating Officer	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Paul Bernard	director	545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Aaron Kim	director	545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Michael Schleifer	director, 10 percent owner, officer: Chief Executive Officer	545 WEST 25TH STREET 20TH FLOOR, NEW YORK NY 10001
Thomas Fratacci	officer: CFO & Treasurer	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001